NTRA
Natera, Inc. Health Care Services-Medical Laboratories Russell 3000
$414.30Close
$57.9BMarket cap
$182.65 – $436.0052-week range
Nov 5, 2026Next report · after the close
Highlights
Strengths
- In a stage-2 uptrend all 8 trend conditions pass
- Leading the market RS 97 · stronger than 97% of stocks over 12 months
- Near its high 5% below its 52-week high
Cautions
- Results soon Nov 5, 2026, in 4 days
- Financial distress Altman Z″ in the distress zone
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
5%
1wk
up 2.6%
price change
1mo
up 0.2%
price change
12-month return
up 114%
market up 11% ·
its own up 104%
F-score
—
— Not assessed
Altman Z″
0.87
Elevated risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
33.8×
price / book
Earnings yield
down 0.5%
EBIT / enterprise value
Cheaper than
17%
of the market · expensive
Revenue growth
up 36%
year on year
EPS growth
—
latest quarter
Sales growth
up 38%
latest quarter · -1 pts
ROE
down 14%
return on equity
Free cash margin
up 5%
$109.1M FCF
D/E
—
long-term debt / equity
Net debt / EBITDA
—
Interest cover
Lossoperating loss
Trade setup
ATR%
4.2%
$17.57 a day · 2×ATR $379.16
RS
97 / 99
vs the universe
Trend
8 / 8
trend template
Relative volume
1.6×
vs 50-day average
Up/down volume
1.40
50 sessions
Implied move
—
no option chain · report Nov 5, 2026
Trend template · 8 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
- Losing money before interest is even paid The company made an operating loss, so interest is not covered at all - the debt is being serviced from cash reserves, asset sales or new borrowing rather than from the business.
- Shareholders diluted The share count rose 5.3% over the year, from 133m to 140m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Aug 6, 2026
Results reaction
Aug 6, 2026+17% vs market2 sessions after results
Financials
- Net -9%
- Free cash 5%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $391.0M | $625.5M | $820.2M | $1.1B | $1.7B | $2.3B |
| Operating income | -$216.3M | -$468.2M | -$541.0M | -$446.2M | -$222.3M | -$309.9M |
| Net income | -$229.7M | -$471.7M | -$547.8M | -$434.8M | -$190.4M | -$208.2M |
| Net margin | -59% | -75% | -67% | -40% | -11% | -9% |
| Earnings per share | -$2.84 | -$5.21 | -$5.57 | -$3.78 | -$1.53 | -$1.52 |
| Free cash flow | -$202.1M | -$376.3M | -$479.2M | -$286.2M | $69.2M | $109.1M |
| Free cash margin | -52% | -60% | -58% | -26% | 4% | 5% |
| Cash | $48.7M | $84.4M | $466.0M | $642.1M | $945.6M | $1.1B |
| Long-term debt | — | $280.4M | $281.7M | $282.9M | — | — |
| Shareholders' equity | $486.2M | $653.3M | $705.7M | $765.3M | $1.2B | $1.7B |
| Shares outstanding | 86.22m | 95.14m | 111.25m | 119.58m | 132.65m | 139.69m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 7, 2026 | Quarterly ↗ | Jun 30, 2026 | 38d |
| May 8, 2026 | Quarterly ↗ | Mar 31, 2026 | 38d |
| Feb 27, 2026 | Annual ↗ | Dec 31, 2025 | 58d |
| Nov 7, 2025 | Quarterly ↗ | Sep 30, 2025 | 38d |
| Aug 8, 2025 | Quarterly ↗ | Jun 30, 2025 | 39d |
| May 9, 2025 | Quarterly ↗ | Mar 31, 2025 | 39d |
| Feb 28, 2025 | Annual ↗ | Dec 31, 2024 | 59d |
| Nov 12, 2024 | Quarterly ↗ | Sep 30, 2024 | 43d |
| Aug 9, 2024 | Quarterly ↗ | Jun 30, 2024 | 40d |
| May 10, 2024 | Quarterly ↗ | Mar 31, 2024 | 40d |
| Feb 29, 2024 | Annual ↗ | Dec 31, 2023 | 60d |
| Nov 9, 2023 | Quarterly ↗ | Sep 30, 2023 | 40d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 6, 2026 | Results ↗ |
| Jul 6, 2026 | Director or officer change ↗ |
| Jun 16, 2026 | Director or officer change · Shareholder vote ↗ |
| Jun 5, 2026 | Director or officer change ↗ |
| May 7, 2026 | Results ↗ |
| Apr 1, 2026 | Director or officer change ↗ |
| Feb 26, 2026 | Results ↗ |
| Jan 12, 2026 | Results ↗ |
| Dec 5, 2025 | Unregistered share sale · Other events ↗ |
| Nov 6, 2025 | Results ↗ |
| Aug 7, 2025 | Results ↗ |
| Jun 18, 2025 | Director or officer change · Shareholder vote ↗ |